loadpatents
name:-0.12084984779358
name:-0.050420999526978
name:-0.036895036697388
Terrett; Jonathan Alexander Patent Filings

Terrett; Jonathan Alexander

Patent Applications and Registrations

Patent applications and USPTO patent grants for Terrett; Jonathan Alexander.The latest application filed is for "anti-cd71 antibodies, activatable anti-cd71 antibodies, and methods of use thereof".

Company Profile
32.52.107
  • Terrett; Jonathan Alexander - Lexington MA
  • Terrett; Jonathan Alexander - Cambridge MA
  • Terrett; Jonathan Alexander - San Jose CA
  • TERRETT; Jonathan Alexander - Cupertino CA
  • Terrett; Jonathan Alexander - Sunnyvale CA
  • - Cupertino CA US
  • Terrett; Jonathan Alexander - Abingdon GB
  • Terrett; Jonathan Alexander - Slough GB
  • Terrett; Jonathan Alexander - Los Altos CA
  • Terrett; Jonathan Alexander - Berkshire GB
  • Terrett; Jonathan Alexander - Oxfordshire GB
  • Terrett, Jonathan Alexander - Berks GB
  • Terrett; Jonathan Alexander - Chelmsford GB
  • TERRETT, JONATHAN ALEXANDER - ESSEX GB
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Anti-cd71 Antibodies, Activatable Anti-cd71 Antibodies, And Methods Of Use Thereof
App 20220306759 - Sagert; Jason Gary ;   et al.
2022-09-29
Anti-pdl1 Antibodies, Activatable Anti-pdl1 Antibodies, And Methods Of Use Thereof
App 20220298245 - West; James William ;   et al.
2022-09-22
Allogeneic Cell Therapy Of B Cell Malignancies Using Genetically Engineered T Cells Targeting Cd19
App 20220249558 - Benton; Mark ;   et al.
2022-08-11
Anti-cd33 Immune Cell Cancer Therapy
App 20220226375 - Terrett; Jonathan Alexander ;   et al.
2022-07-21
Allogeneic cell therapy of B cell malignancies using genetically engineered T cells targeting CD19
Grant 11,389,481 - Benton , et al. July 19, 2
2022-07-19
Cancer Treatment Using Cd38 Inhibitor And/or Lenalidomide And T-cells Expressing A Chimeric Antigen Receptor
App 20220202859 - TERRETT; Jonathan Alexander ;   et al.
2022-06-30
Co-use Of Lenalidomide With Car-t Cells
App 20220193134 - DAR; Henia ;   et al.
2022-06-23
Allogeneic Cell Therapy Of B Cell Malignancies Using Genetically Engineered T Cells Targeting Cd19
App 20220118019 - BENTON; Mark ;   et al.
2022-04-21
Materials and methods for engineering cells and uses thereof in immuno-oncology
Grant 11,298,378 - Terrett , et al. April 12, 2
2022-04-12
Anti-CD71 antibodies, activatable anti-CD71 antibodies, and methods of use thereof
Grant 11,267,896 - Sagert , et al. March 8, 2
2022-03-08
Methods and compositions for treating cancer
Grant 11,254,912 - Terrett , et al. February 22, 2
2022-02-22
Allogeneic Cell Therapy Of Acute Lymphoblastic Leukemia Using Genetically Engineered T Cells Targeting Cd19
App 20220023344 - TERRETT; Jonathan Alexander ;   et al.
2022-01-27
Use Of Chimeric Antigen Receptor T Cells And Nk Cell Inhibitors For Treating Cancer
App 20220008473 - Terrett; Jonathan Alexander ;   et al.
2022-01-13
Materials and methods for engineering cells and uses thereof in immuno-oncology
Grant 11,207,351 - Terrett , et al. December 28, 2
2021-12-28
Materials and methods for engineering cells and uses thereof in immuno-oncology
Grant 11,202,802 - Terrett , et al. December 21, 2
2021-12-21
Materials and methods for engineering cells and uses thereof in immuno-oncology
Grant 11,191,783 - Terrett , et al. December 7, 2
2021-12-07
Conjugated Antiboides Against Ly75 For The Treatment Of Cancer
App 20210371541 - Terrett; Jonathan Alexander ;   et al.
2021-12-02
Genetically Engineered Car T Cells That Secret Interleukin-12 And Therapeutic Uses Thereof
App 20210363212 - Ghonime; Mohammed ;   et al.
2021-11-25
Matrix Metalloprotease-cleavable And Serine Protease-cleavable Substrates And Methods Of Use Thereof
App 20210355208 - MOORE; Stephen James ;   et al.
2021-11-18
Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods of use thereof
Grant 11,174,316 - West , et al. November 16, 2
2021-11-16
Masked Chimeric Antigen Receptor Specific To Tyrosine-protein Kinase Like 7 (ptk7) And Immune Cells Expressing Such
App 20210347913 - Sagert; Jason ;   et al.
2021-11-11
Matrix Metalloprotease-cleavable And Serine Protease-cleavable Substrates And Methods Of Use Thereof
App 20210347886 - MOORE; Stephen James ;   et al.
2021-11-11
Materials and methods for engineering cells and uses thereof in immuno-oncology
Grant 11,166,985 - Terrett , et al. November 9, 2
2021-11-09
Materials and methods for engineering cells and uses thereof in immuno-oncology
Grant 11,135,247 - Terrett , et al. October 5, 2
2021-10-05
Anti-ptk7 Immune Cell Cancer Therapy
App 20210290678 - Terrett; Jonathan Alexander ;   et al.
2021-09-23
Anti-liv1 Immune Cell Cancer Therapy
App 20210292429 - Terrett; Jonathan Alexander ;   et al.
2021-09-23
Allogeneic Cell Therapy Of B Cell Malignancies Using Genetically Engineered T Cells Targeting Cd19
App 20210268026 - Benton; Mark ;   et al.
2021-09-02
Methods And Compositions For Treating Cancer
App 20210261919 - Terrett; Jonathan Alexander ;   et al.
2021-08-26
Materials And Methods For Engineering Cells And Uses Thereof In Immuno-oncology
App 20210252060 - Terrett; Jonathan Alexander ;   et al.
2021-08-19
Methods And Compositions For Treating Cancer
App 20210246425 - Terrett; Jonathan Alexander ;   et al.
2021-08-12
Materials And Methods For Engineering Cells And Uses Thereof In Immuno-oncology
App 20210236552 - Terrett; Jonathan Alexander ;   et al.
2021-08-05
Materials And Methods For Engineering Cells And Uses Thereof In Immuno-oncology
App 20210236551 - TERRETT; Jonathan Alexander ;   et al.
2021-08-05
Materials and methods for engineering cells and uses thereof in immuno-oncology
Grant 11,071,755 - Terrett , et al. July 27, 2
2021-07-27
Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof
Grant 11,046,759 - Moore , et al. June 29, 2
2021-06-29
Materials and methods for engineering cells and uses thereof in immuno-oncology
Grant 11,013,767 - Terrett , et al. May 25, 2
2021-05-25
Antibodies to bone marrow stromal antigen 1
Grant 10,982,005 - Rohlff , et al. April 20, 2
2021-04-20
Materials And Methods For Engineering Cells And Uses Thereof In Immuno-oncology
App 20210108174 - TERRETT; Jonathan Alexander ;   et al.
2021-04-15
Materials And Methods For Engineering Cells And Uses Thereof In Immuno-oncology
App 20210085718 - Terrett; Jonathan Alexander ;   et al.
2021-03-25
Genetically Engineered T Cells Having Improved Persistence In Culture
App 20210079347 - Terrett; Jonathan Alexander ;   et al.
2021-03-18
Methods And Compositions For Treating Cancer
App 20210060072 - Terrett; Jonathan Alexander ;   et al.
2021-03-04
Materials and methods for engineering cells and uses thereof in immuno-oncology
Grant 10,881,689 - Terrett , et al. January 5, 2
2021-01-05
Materials And Methods For Engineering Cells And Uses Thereof In Immuno-oncology
App 20200405761 - Terrett; Jonathan Alexander ;   et al.
2020-12-31
Materials And Methods For Engineering Cells And Uses Thereof In Immuno-oncology
App 20200405764 - Terrett; Jonathan Alexander ;   et al.
2020-12-31
Materials and methods for engineering cells and uses thereof in immuno-oncology
Grant 10,857,184 - Terrett , et al. December 8, 2
2020-12-08
Materials And Methods For Engineering Cells And Uses Thereof In Immuno-oncology
App 20200330518 - Terrett; Jonathan Alexander ;   et al.
2020-10-22
Anti-cd166 Antibodies, Activatable Anti-cd166 Antibodies, And Methods Of Use Thereof
App 20200291113 - WEST; James William ;   et al.
2020-09-17
Anti-CD166 antibodies, activatable anti-CD166 antibodies, and methods of use thereof
Grant 10,745,481 - West , et al. A
2020-08-18
Materials and methods for engineering cells and uses thereof in immuno-oncology
Grant 10,736,919 - Terrett , et al. A
2020-08-11
Materials and methods for engineering cells and uses thereof in immuno-oncology
Grant 10,729,725 - Terrett , et al.
2020-08-04
Anti-liv1 Immune Cell Cancer Therapy
App 20200231699 - Terrett; Jonathan Alexander ;   et al.
2020-07-23
Anti-pdl1 Antibodies, Activatable Anti-pdl1 Antibodies, And Methods Of Use Thereof
App 20200231677 - West; James William ;   et al.
2020-07-23
Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods of use thereof
Grant 10,669,339 - West , et al.
2020-06-02
Anti-ptk7 Immune Cell Cancer Therapy
App 20200140815 - Terrett; Jonathan Alexander ;   et al.
2020-05-07
Anti-CD166 antibodies, activatable anti-CD166 antibodies, and methods of use thereof
Grant 10577420 -
2020-03-03
Methods And Compositions For Treating Cancer
App 20200063100 - TERRETT; Jonathan Alexander ;   et al.
2020-02-27
Anti-pdl1 Antibodies, Activatable Anti-pdl1 Antibodies, And Methods Of Use Thereof
App 20190382493 - West; James William ;   et al.
2019-12-19
Materials And Methods For Engineering Cells And Uses Thereof In Immuno-oncology
App 20190365808 - Terrett; Jonathan Alexander ;   et al.
2019-12-05
Materials And Methods For Engineering Cells And Uses Thereof In Immuno-oncology
App 20190365809 - Terrett; Jonathan Alexander ;   et al.
2019-12-05
Antibodies To Bone Marrow Stromal Antigen 1
App 20190322764 - ROHLFF; Christian ;   et al.
2019-10-24
Materials And Methods For Engineering Cells And Uses Thereof In Immuno-oncology
App 20190314414 - TERRETT; Jonathan Alexander ;   et al.
2019-10-17
Materials And Methods For Engineering Cells And Uses Thereof In Immuno-oncology
App 20190314413 - TERRETT; Jonathan Alexander ;   et al.
2019-10-17
Anti-itga3 Antibodies, Activatable Anti-itga3 Antibodies, And Methods Of Use Thereof
App 20190309072 - SAGERT; Jason Gary ;   et al.
2019-10-10
Matrix Metalloprotease-cleavable And Serine Protease-cleavable Substrates And Methods Of Use Thereof
App 20190241652 - Moore; Stephen James ;   et al.
2019-08-08
Anti-cd71 Antibodies, Activatable Anti-cd71 Antibodies, And Methods Of Use Thereof
App 20190202927 - Sagert; Jason Gary ;   et al.
2019-07-04
Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods of thereof
Grant 10,336,824 - West , et al.
2019-07-02
Anti-cd71 Activatable Antibody Drug Conjugates And Methods Of Use Thereof
App 20190111150 - SINGH; Shweta ;   et al.
2019-04-18
Conjugated Antibodies Against Ly75 For The Treatment Of Cancer
App 20190106506 - Terrett; Jonathan Alexander ;   et al.
2019-04-11
Nucleic acid encoding bone marrow stromal antigen 1 antibody
Grant 10,239,956 - Rohlff , et al.
2019-03-26
Anti-ITGA3 antibodies, activatable anti-ITGA3 antibodies, and methods of use thereof
Grant 10,233,244 - Sagert , et al.
2019-03-19
Anti-CD71 antibodies, activatable anti-CD71 antibodies, and methods of use thereof
Grant 10,179,817 - Sagert , et al. Ja
2019-01-15
Materials And Methods For Engineering Cells And Uses Thereof In Immuno-oncology
App 20180325955 - Terrett; Jonathan Alexander ;   et al.
2018-11-15
Cd147 Antibodies, Activatable Cd147 Antibodies, And Methods Of Making And Use Thereof
App 20180303952 - SAGERT; Jason Gary ;   et al.
2018-10-25
Conjugated antibodies against LY75 for the treatment of cancer
Grant 10,081,682 - Terrett , et al. September 25, 2
2018-09-25
Antibodies
Grant 9,932,411 - Terrett , et al. April 3, 2
2018-04-03
Methods Of Treating Acute Myeloid Leukemia With Antibodies To Bone Marrow Stromal Antigen 1
App 20170313785 - ROHLFF; Christian ;   et al.
2017-11-02
Methods of treating acute myeloid leukemia with antibodies to bone marrow stromal antigen 1
Grant 9,732,160 - Rohlff , et al. August 15, 2
2017-08-15
Anti-itga3 Antibodies, Activatable Anti-itga3 Antibodies, And Methods Of Use Thereof
App 20160355592 - Sagert; Jason Gary ;   et al.
2016-12-08
Anti-cd71 Antibodies, Activatable Anti-cd71 Antibodies, And Methods Of Use Thereof
App 20160355599 - Sagert; Jason Gary ;   et al.
2016-12-08
Anti-cd166 Antibodies, Activatable Anti-cd166 Antibodies, And Methods Of Use Thereof
App 20160355587 - West; James William ;   et al.
2016-12-08
Treating lung cancer using human monoclonal antibodies to protein tyrosine kinase 7 (PTK7)
Grant 9,505,845 - Terrett , et al. November 29, 2
2016-11-29
Anti-pdl1 Antibodies, Activatable Anti-pdl1 Antibodies, And Methods Of Use Thereof
App 20160311903 - West; James William ;   et al.
2016-10-27
Matrix Metalloprotease-cleavable And Serine Protease-cleavable Substrates And Methods Of Use Thereof
App 20160289324 - Moore; Stephen James ;   et al.
2016-10-06
Antibodies Anti Matriptase For The Treatment Of Cancer
App 20160289338 - TERRETT; Jonathan Alexander ;   et al.
2016-10-06
Conjugated Antibodies Against LY75 for the Treatment of Cancer
App 20160257760 - Terrett; Jonathan Alexander ;   et al.
2016-09-08
Antibodies Specific To Cadherin-17
App 20160039933 - ROHLFF; Christian ;   et al.
2016-02-11
Antibodies To Bone Marrow Stromal Antigen 1
App 20160002354 - Rohlff; Christian ;   et al.
2016-01-07
Anti-ROR1 antibodies and methods of use for treatment of cancer
Grant 9,228,023 - Rohlff , et al. January 5, 2
2016-01-05
Monoclonal antibodies against Glypican-3
Grant 9,217,033 - Terrett , et al. December 22, 2
2015-12-22
Antibodies specific to cadherin-17
Grant 9,181,339 - Rohlff , et al. November 10, 2
2015-11-10
Antibodies to bone marrow stromal antigen 1
Grant 9,175,092 - Rohlff , et al. November 3, 2
2015-11-03
Human monoclonal antibodies to protein tyrosine kinase 7 (PTK7)
Grant 9,102,738 - Terrett , et al. August 11, 2
2015-08-11
Antibodies
App 20150093392 - TERRETT; Jonathan Alexander ;   et al.
2015-04-02
Monoclonal Antibodies Against Glypican-3
App 20140186892 - Terrett; Jonathan Alexander ;   et al.
2014-07-03
Monoclonal antibodies against glypican-3
Grant 8,680,247 - Terrett , et al. March 25, 2
2014-03-25
Protein
App 20140024048 - Rohlff; Christian ;   et al.
2014-01-23
Antibodies
App 20130273068 - ROHLFF; Christian ;   et al.
2013-10-17
Antibodies
App 20130259878 - Terrett; Jonathan Alexander
2013-10-03
Anti-ror1 Antibodies
App 20130251723 - Rohlff; Christian ;   et al.
2013-09-26
Antibody drug conjugate treatment of colorectal cancer
Grant 8,535,677 - Rohlff , et al. September 17, 2
2013-09-17
Fully Human Antibodies Specific To Cadm1
App 20130156788 - TERRETT; Jonathan Alexander ;   et al.
2013-06-20
Matriptase protein and uses thereof
Grant 8,420,091 - Rohlff , et al. April 16, 2
2013-04-16
Fully human antibodies specific to CADM1
Grant 8,420,084 - Terrett , et al. April 16, 2
2013-04-16
ROR1 as Therapeutic and Diagnostic Target
App 20120282177 - Rohlff; Christian ;   et al.
2012-11-08
Antibodies
App 20120231004 - Rohlff; Christian ;   et al.
2012-09-13
Human Monoclonal Antibodies To Protein Tyrosine Kinase 7 (ptk7) And Methods For Using Anti-ptk7 Antibodies
App 20120219557 - TERRETT; Jonathan Alexander ;   et al.
2012-08-30
Human Monoclonal Antibodies To Protein Tyrosine Kinase 7 (ptk7) And Methods For Using Anti-ptk7 Antibodies
App 20120207764 - TERRETT; Jonathan Alexander ;   et al.
2012-08-16
Human monoclonal antibodies to protein tyrosine kinase 7 (PTK7) and methods for using anti-PTK7 antibodies
Grant 8,222,375 - Terrett , et al. July 17, 2
2012-07-17
Antibodies Specific to Cadherin-17
App 20120114672 - Rohlff; Christian ;   et al.
2012-05-10
Fully Human Antibodies Specific To Cadm1
App 20120093826 - Terrett; Jonathan Alexander ;   et al.
2012-04-19
Monoclonal Antibody Partner Molecule Conjugates Directed To Protein Tyrosine Kinase 7 (ptk7)
App 20120027782 - Terrett; Jonathan Alexander ;   et al.
2012-02-02
Protein
App 20110195026 - ROHLFF; Christian ;   et al.
2011-08-11
Ephrin-b Receptor Protein Involved In Carcinoma
App 20110150877 - Boyd; Robert Simon ;   et al.
2011-06-23
Matriptase Protein And Uses Thereof
App 20100285017 - Rohlff; Christian ;   et al.
2010-11-11
Methods for diagnosis and treatment of epithelial-derived cancers
Grant 7,745,156 - Terrett June 29, 2
2010-06-29
Human Monoclonal Antibodies To Protein Tyrosine Kinase 7 (ptk7) And Methods For Using Anti-ptk7 Antibodies
App 20100034826 - Terrett; Jonathan Alexander ;   et al.
2010-02-11
Ephrin-B receptor protein involved in carcinoma
Grant 7,655,426 - Boyd , et al. February 2, 2
2010-02-02
Diagnostic and therapeutic methods
App 20100015152 - Boyd; Robert Simon ;   et al.
2010-01-21
Diagnosis of carcinoma using RAIG1 polypeptides
App 20090258019 - Terrett; Jonathan Alexander
2009-10-15
Substances
App 20090246201 - McKenzie; Edward Alexander ;   et al.
2009-10-01
Methods for diagnosis and treatment of epithelial-derived cancers
App 20090148439 - Terrett; Jonathan Alexander
2009-06-11
Novel cancer associated protein
App 20080226644 - Terrett; Jonathan Alexander
2008-09-18
Cancer associated protein
Grant 7,297,760 - Terrett November 20, 2
2007-11-20
Heparanase-like polypeptides
Grant 7,273,744 - McKenzie , et al. September 25, 2
2007-09-25
Proteins
App 20070212368 - Boyd; Robert Simon ;   et al.
2007-09-13
Methods for diagnosis and treatment of epithelial-derived cancers
Grant 7,261,892 - Terrett August 28, 2
2007-08-28
Protein involved in carcinoma
App 20060147478 - Terrett; Jonathan Alexander
2006-07-06
Protein involved in cancer
App 20060088537 - Terrett; Jonathan Alexander
2006-04-27
Diagnosis of Carcinoma Using RAIG1 Polypeptides
App 20050282165 - Terrett, Jonathan Alexander
2005-12-22
Ephrin-b receptor protein involved in carcinoma
App 20050260209 - Boyd, Robert Simon ;   et al.
2005-11-24
Methods for diagnosis and treatment of epithelial-derived cancers
App 20050123547 - Terrett, Jonathan Alexander
2005-06-09
Methods for diagnosis and treatment of epithelial-derived cancers
App 20050118656 - Terrett, Jonathan Alexander
2005-06-02
Method of protein analysis
App 20040253636 - Soloviev, Mikhail ;   et al.
2004-12-16
Cancer associated protein
App 20040166517 - Terrett, Jonathan Alexander
2004-08-26
Diagnostic and therapeutic methods
App 20040141974 - Boyd, Robert Simon ;   et al.
2004-07-22
Novel cancer associated protein
App 20040142367 - Terrett, Jonathan Alexander
2004-07-22
Proteins, genes and their use for diagnosis and treatment of schizophrenia
App 20040110938 - Parekh, Rajesh Bhikhu ;   et al.
2004-06-10
BCMP84 protein, compositions, diagnostic and therapeutic uses thereof
App 20040053830 - Adam, Paul J. ;   et al.
2004-03-18
Proteins, genes and their use for diagnosis and treatment of chronic asthma
App 20040043425 - Terrett, Jonathan Alexander ;   et al.
2004-03-04
Methods for treatment using novel ligands of the neuropeptide receptor HFGAN72
Grant 6,664,229 - Hagan , et al. December 16, 2
2003-12-16
Proteins, compositions, diagnostic and therapeutic uses thereof
App 20030130214 - Boyd, Robert Simon ;   et al.
2003-07-10
Proteins
App 20030099662 - Boyd, Robert Simon ;   et al.
2003-05-29
ADPI-41, a novel protein isolated from brain tissue homogenate and uses therefor
App 20030092614 - Herath, Herath Mudiyanselage Athula Chandrasiri ;   et al.
2003-05-15
Methods For Treatment Using Novel Ligands Of The Neuropeptide Receptor Hfgan72
App 20030087801 - HAGAN, JAMES JOSEPH ;   et al.
2003-05-08
Substances
App 20030083254 - McKenzie, Edward Alexander ;   et al.
2003-05-01
Proteins, genes and their use for diagnosis and treatment of bipolar affective disorder (BAD) and unipolar depression
App 20030032773 - Herath, Herath Mudiyanselage Athula Chandrasiri ;   et al.
2003-02-13
Diagnosis and treatment and related preparations
App 20030017456 - Boyd, Robert Simon ;   et al.
2003-01-23
Diagnostic and therapeutic methods
App 20020111303 - Boyd, Robert Simon ;   et al.
2002-08-15
Tubby 2 polypeptides
App 20020082385 - Terrett, Jonathan Alexander ;   et al.
2002-06-27
Detection of peptides
App 20020055186 - Barry, Richard ;   et al.
2002-05-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed